ARTICLE | Company News
Beyond Genomics, AZN toxicology deal
February 3, 2004 8:00 AM UTC
Beyond Genomics (Waltham, Mass.) will use its systems biology platform and BioSystematics informatics tools to identify biomarkers of drug-induced toxicity for AstraZeneca (LSE:AZN; AZN). Beyond Genom...